SI2561069T1
Lysosomal storage disease enzyme
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
16 claims: 3 independent, 13 dependent
- 1An enzyme for the treatment of lysosomal storage Patent claims Encim za bolezen lizosomskega shranjevanja Patentni zahtevki 1. A pharmaceutical formulation comprising the isolated human recombinant lysosomal acid lipase (rhLAL) in combination with a pharmaceutically acceptable carrier, diluent or excipient, wherein said rhLAL comprises one or more N-glycan structures where rhLAL N-linked glycosylated at the Asn " Asn * ®, Asn * '* ", Asn ^^^ and Asn ^" "of SEQ ID NO:2, and wherein the pharmaceutical formulation is an aqueous solution having a pH of between 5.6 and 6.2 or a pH of 5 , 9 ± 0.2. 1. Farmacevtska formulacija, ki obsega izolirano humano rekombinantno lizosomsko kislinsko lipazo (rhLAL) v kombinaciji s farmacevtsko sprejemljivim nosilcem, razredčilom ali ekscipientom, pri čemer navedena rhLAL obsega eno ali več N-glikanskih struktur, kjer je rhLAL N-vezano glikozilirana na Asn'^ Asn*®, Asn*'*”, Asn^^^ in Asn^”“ od SEQ ID NO: 2, in kjer je farmacevtska formulacija vodna raztopina, ki ima pH med 5,6 in 6,2 ali pH s 5,9 ± 0,2.
- 15Farmacevtska formulacija po katerem koli od predhodnih zahtevkov, kjer je pH farmacevtske formulacije 5,9 ± 0,2. A pharmaceutical formulation according to any of the preceding claims, wherein the pH of the pharmaceutical formulation is 5.9 ± 0.2.
- 16A pharmaceutical formulation as claimed in any one of the preceding claims, wherein said pharmaceutical formulation comprises an excipient suitable for the formulation by intravenous infusion or injection, is chosen from trisodium citrate dehydrate, citric acid and human serum albumin. 16. Farmacevtska formulacija po katerem koli od predhodnih zahtevkov, kjer farmacevtska formulacija obsega ekscipient, primeren za formulacijo za intravensko infuzijo ali injekcijo, izbrano izmed trinatrijevega citrata dehidrata, citronske kisline in humanega serumskega albumina.
Independent claims3
143 members in 33 offices
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 34317710 | United States of America | P | |
| 39637610 | United States of America | P | |
| 40301110 | United States of America | P | |
| 45601410 | United States of America | P | |
| 201161432372 | United States of America | P | |
| 11772834 | European Patent Office (EPO) | A | |
| 2011033699 | United States of America | W |
Members143
| Document | Office | Kind | |
|---|---|---|---|
| CA2796607A1 | Canada | A1 | |
| CA2995446A1 | Canada | A1 | |
| WO2011133960A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2012064055A1 | United States of America | A1 | |
| CA2810999A1 | Canada | A1 | |
| CA3209456A1 | Canada | A1 | |
| WO2012050695A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201225971A | Taiwan Province of China | A | |
| WO2011133960A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2011242461A1 | Australia | A1 | |
| IL222513D0 | Israel | D0 | |
| AR082953A1 | Argentina | A1 | |
| EP2561069A2 | European Patent Office (EPO) | A2 | |
| CN102985538A | China | A | |
| AU2011314293A1 | Australia | A1 | |
| MX2012012356A | Mexico | A | |
| SG188456A1 | Singapore | A1 | |
| WO2011133960A9 | World Intellectual Property Organization (WIPO) | A9 | |
| JP2013526856A | Japan | A | |
| CN103200958A | China | A | |
| CO6710913A2 | Colombia | A2 | |
| EP2613798A1 | European Patent Office (EPO) | A1 | |
| US2013209436A1 | United States of America | A1 | |
| MX2013002704A | Mexico | A | |
| CL2013000664A1 | Chile | A1 | |
| KR20130113312A | Republic of Korea | A | |
| JP2013540733A | Japan | A | |
| HK1183059A1 | Hong Kong, China | A1 | |
| KR20130136990A | Republic of Korea | A | |
| US8663631B2 | United States of America | B2 | |
| EP2561069A4 | European Patent Office (EPO) | A4 | |
| RU2012149936A | Russian Federation | A | |
| NZ608292A | New Zealand | A | |
| RU2013110491A | Russian Federation | A | |
| US2014348752A1 | United States of America | A1 | |
| US2015030582A1 | United States of America | A1 | |
| EP2613798B1 | European Patent Office (EPO) | B1 | |
| JP2015052014A | Japan | A | |
| JP5693728B2 | Japan | B2 | |
| KR20150038636A | Republic of Korea | A | |
| DK2613798T3 | Denmark | T3 | |
| TWI482625B | Taiwan Province of China | B | |
| ES2535605T3 | Spain | T3 | |
| ME02062B | Montenegro | B | |
| RU2550961C2 | Russian Federation | C2 | |
| HRP20150438T1 | Croatia | T1 | |
| SI2613798T1 | Slovenia | T1 | |
| PT2613798E | Portugal | E | |
| AU2011314293B2 | Australia | B2 | |
| SMT201500108B | San Marino | B | |
| PL2613798T3 | Poland | T3 | |
| RS53947B1 | Serbia | B1 | |
| CN102985538B | China | B | |
| AU2015218427A1 | Australia | A1 | |
| UA109672C2 | Ukraine | C2 | |
| AU2011242461B2 | Australia | B2 | |
| SG10201507199UA | Singapore | A | |
| JP2015204842A | Japan | A | |
| CN105214076A | China | A | |
| EP2977057A1 | European Patent Office (EPO) | A1 | |
| US2016051638A1 | United States of America | A1 | |
| NZ700824A | New Zealand | A | |
| CN105457018A | China | A | |
| MX338426B | Mexico | B | |
| JP5925187B2 | Japan | B2 | |
| IL225095A | Israel | A | |
| IL245283D0 | Israel | D0 | |
| JP2016145257A | Japan | A | |
| HK1215532A1 | Hong Kong, China | A1 | |
| JP2016190867A | Japan | A | |
| BR112012027143A2 | Brazil | A2 | |
| EP2561069B1 | European Patent Office (EPO) | B1 | |
| HK1219655A1 | Hong Kong, China | A1 | |
| DK2561069T3 | Denmark | T3 | |
| HK1220907A1 | Hong Kong, China | A1 | |
| PT2561069T | Portugal | T | |
| KR101742346B1 | Republic of Korea | B1 | |
| JP6156882B2 | Japan | B2 | |
| ES2627535T3 | Spain | T3 | |
| IL252115D0 | Israel | D0 | |
| SI2561069T1This record | Slovenia | T1 | |
| EP3205351A1 | European Patent Office (EPO) | A1 | |
| PL2561069T3 | Poland | T3 | |
| BR112012027143A8 | Brazil | A8 | |
| BR112013005673A2 | Brazil | A2 | |
| AU2015218427B2 | Australia | B2 | |
| JP6212081B2 | Japan | B2 | |
| US2017314000A1 | United States of America | A1 | |
| HUE033217T2 | Hungary | T2 | |
| EP2613798B2 | European Patent Office (EPO) | B2 | |
| CY1116544T1 | Cyprus | T1 | |
| DK2613798T4 | Denmark | T4 | |
| ES2535605T5 | Spain | T5 | |
| SI2613798T2 | Slovenia | T2 | |
| JP2018100289A | Japan | A | |
| PL2613798T5 | Poland | T5 | |
| RU2017105260A | Russian Federation | A | |
| NZ715014A | New Zealand | A | |
| US10166274B2 | United States of America | B2 | |
| RU2015151189A | Russian Federation | A |
Showing 100 of 143
Numbers
- Publication
- 2561069
- Application
- 31204
Titles2
- English
- LYSOSOMAL STORAGE DISEASE ENZYME
- Slovenian
- Encim za bolezen lizosomskega shranjevanja
Classification
- CPC, 22
- C12N9/20
- A61K35/00
- C12Y301/01013
- A01K67/0278
- A01K2217/052
- A01K2227/30
- A01K2267/01
- A61K31/194
- A61P1/00
- A61P1/16
- A61P3/00
- A61P3/06
- A61P35/04
- A61P43/00
- A61P9/00
- A61K38/465
- C12N15/86
- C12N2740/11043
- C12N2740/11045
- C12N2760/20222
- A61K38/385
- C12N2740/10041
- IPC, 5
- A01K67 00
- A61K38 00
- A61K31 00
- A61P3 00
- C12N9 00